Detalhe da pesquisa
1.
The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast.
Mol Biol Rep
; 51(1): 331, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38393465
2.
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Prostate
; 79(4): 414-424, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30560549
3.
Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis.
Breast Cancer Res
; 20(1): 54, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29898755
4.
Modeling triple-negative breast cancer heterogeneity: Effects of stromal macrophages, fibroblasts and tumor vasculature.
J Theor Biol
; 452: 56-68, 2018 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29750999
5.
HOX genes: Major actors in resistance to selective endocrine response modifiers.
Biochim Biophys Acta
; 1865(2): 105-10, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26803986
6.
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway.
Proc Natl Acad Sci U S A
; 109(8): 2736-41, 2012 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21690342
7.
Crosstalk between triple negative breast cancer and microenvironment.
Oncotarget
; 14: 284-293, 2023 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999995
8.
Overview of the therapeutic strategies for ER positive breast cancer.
Biochem Pharmacol
; 212: 115552, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068524
9.
Mirk regulates the exit of colon cancer cells from quiescence.
J Biol Chem
; 284(34): 22916-25, 2009 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19542220
10.
BRCA1: linking HOX to breast cancer suppression.
Breast Cancer Res
; 12(4): 306, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20727230
11.
Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy.
Cancer Biol Ther
; 21(6): 560-569, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32213106
12.
The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
Cancer Res
; 67(15): 7247-55, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17671193
13.
Addendum: Crosstalk between triple negative breast cancer and microenvironment.
Oncotarget
; 14: 810, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713335
14.
Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis.
Oncotarget
; 8(36): 60210-60222, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947965
15.
Inhibitors of STAT3, ß-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.
Mol Oncol
; 11(5): 552-566, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28296140
16.
The Widening Sphere of Influence of HOXB7 in Solid Tumors.
Cancer Res
; 76(10): 2857-62, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27197229
17.
Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer.
Oncotarget
; 7(22): 33306-15, 2016 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27119227
18.
Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer.
Cancer Res
; 76(7): 2013-2024, 2016 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26787836
19.
A pivotal role for HOXB7 protein in endocrine resistant breast cancer.
Oncoscience
; 2(11): 917-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26697525
20.
HOXB7 promotes malignant progression by activating the TGFß signaling pathway.
Cancer Res
; 75(4): 709-19, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25542862